[{"address1": "Essener Bogen 7", "city": "Hamburg", "zip": "22419", "country": "Germany", "phone": "49 40 560 81 0", "website": "https://www.evotec.com", "industry": "Drug Manufacturers - Specialty & Generic", "industryKey": "drug-manufacturers-specialty-generic", "industryDisp": "Drug Manufacturers - Specialty & Generic", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Evotec SE operates as drug discovery and development partner for the pharmaceutical and biotechnology industry worldwide. It operates in two segments, Shared R&D and Just Evotec Biologics. The company is developing pharmaceutical products in various therapeutic areas, such as oncology, autoimmune, cancer, diabetes, heart failure, fibrosis, immunology, pain and inflammation, infectious, kidney, liver, rare, respiratory, fibrotic and metabolic disease; central nervous system (CNS) and cardio metabolic disorders; and animal and women health. The company has collaboration agreements with Mass General Brigham and Joslin Diabetes Center focusing on cardiometabolic diseases; BMS antiviral; Novo Nordisk cell therapy; University of Oxford; German Cancer Research Center; University Hospital in Hamburg; University of Toronto, Harvard, and Yale; Johns Hopkins University; Ospedale San Raffaele (OSR); and National University of Singapore. It also has a partnership with LAB282, LAB150, beLAB2122, beLAB1407, LAB eN\u00b2, Danube Labs, VC Amplitude Ventures, LaB eN2, and 65LAB; Bayer, Novo Nordisk, Eli Lilly, and Novartis company for kidney disease; and Sandoz, patient advocacy groups, and venture capital, as well as a strategic research collaboration agreement with Bristol Myers Squibb to build a molecular glue based pipeline for unmet medical needs. The company was formerly known as Evotec AG and changed its name to Evotec SE in April 2019. Evotec SE was incorporated in 1993 and is headquartered in Hamburg, Germany.", "fullTimeEmployees": 4740, "companyOfficers": [{"maxAge": 1, "name": "Dr. Christian  Wojczewski Ph.D.", "age": 51, "title": "CEO & Management Board Member", "yearBorn": 1973, "fiscalYear": 2024, "totalPay": 1208640, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Cord  Dohrmann Ph.D.", "age": 60, "title": "Chief Scientific Officer & Member of Management Board", "yearBorn": 1964, "fiscalYear": 2024, "totalPay": 564785, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Aurelie  Dalbiez", "age": 47, "title": "Chief People Officer & Member of Management Board", "yearBorn": 1977, "fiscalYear": 2024, "totalPay": 529768, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Paul  Hitchin", "title": "Chief Financial Officer", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Volker  Braun", "title": "Executive VP and Head of Global Investor Relations & ESG", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Christian  Dargel", "age": 52, "title": "EVP Global Head of Legal & Compliance", "yearBorn": 1972, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Ian M. Hunneyball", "age": 74, "title": "Senior Vice President of Programme Management & Clinical Operations", "yearBorn": 1950, "fiscalYear": 2024, "totalPay": 131030, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. David  Hallet", "title": "Executive Vice President", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Uwe  Andag", "title": "EVP Head of Metabolic Diseases", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Christiane  Honisch", "title": "SVP Head of Diagnostics", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 4.23, "open": 4.29, "dayLow": 4.27, "dayHigh": 4.38, "regularMarketPreviousClose": 4.23, "regularMarketOpen": 4.29, "regularMarketDayLow": 4.27, "regularMarketDayHigh": 4.38, "payoutRatio": 0.0, "beta": 1.09, "forwardPE": -22.578947, "volume": 55183, "regularMarketVolume": 55183, "averageVolume": 83459, "averageVolume10days": 82770, "averageDailyVolume10Day": 82770, "bid": 4.24, "ask": 4.34, "bidSize": 1, "askSize": 1, "marketCap": 1527862016, "fiftyTwoWeekLow": 2.84, "fiftyTwoWeekHigh": 5.68, "priceToSalesTrailing12Months": 1.9170958, "fiftyDayAverage": 3.6894, "twoHundredDayAverage": 3.977, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 803606144, "profitMargins": -0.24603, "floatShares": 130774311, "sharesOutstanding": 355107008, "sharesShort": 660820, "sharesShortPriorMonth": 723757, "sharesShortPreviousMonthDate": 1741910400, "dateShortInterest": 1744675200, "sharesPercentSharesOut": 0.0019, "heldPercentInsiders": 0.0, "heldPercentInstitutions": 0.02536, "shortRatio": 6.76, "shortPercentOfFloat": 0.0019, "impliedSharesOutstanding": 356144992, "bookValue": 5.37, "priceToBook": 0.79888266, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1735603200, "netIncomeToCommon": -196078000, "trailingEps": -0.63, "forwardEps": -0.19, "lastSplitFactor": "4:1", "lastSplitDate": 1634688000, "enterpriseToRevenue": 1.008, "enterpriseToEbitda": 1234.418, "52WeekChange": -0.17500001, "SandP52WeekChange": 0.09765589, "quoteType": "EQUITY", "currentPrice": 4.29, "targetHighPrice": 9.603255, "targetLowPrice": 2.9818017, "targetMeanPrice": 6.4539385, "targetMedianPrice": 6.958291, "recommendationMean": 2.4, "recommendationKey": "buy", "numberOfAnalystOpinions": 5, "totalCash": 396800000, "totalCashPerShare": 2.237, "ebitda": 651000, "totalDebt": 439420000, "quickRatio": 1.744, "currentRatio": 1.979, "totalRevenue": 796966976, "debtToEquity": 46.132, "revenuePerShare": 2.2475, "returnOnAssets": -0.02369, "returnOnEquity": -0.18922001, "grossProfits": 114881000, "freeCashflow": -85913248, "operatingCashflow": 18220000, "revenueGrowth": 0.099, "grossMargins": 0.14415, "ebitdaMargins": 0.00082, "operatingMargins": 0.0053, "financialCurrency": "EUR", "symbol": "EVO", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "fiftyTwoWeekLowChange": 1.45, "fiftyTwoWeekLowChangePercent": 0.51056343, "fiftyTwoWeekRange": "2.84 - 5.68", "fiftyTwoWeekHighChange": -1.3899999, "fiftyTwoWeekHighChangePercent": -0.2447183, "fiftyTwoWeekChangePercent": -17.500002, "earningsTimestamp": 1746508800, "earningsTimestampStart": 1746508800, "earningsTimestampEnd": 1746508800, "earningsCallTimestampStart": 1746532800, "earningsCallTimestampEnd": 1746532800, "isEarningsDateEstimate": false, "epsTrailingTwelveMonths": -0.63, "epsForward": -0.19, "epsCurrentYear": -0.31, "priceEpsCurrentYear": -13.83871, "fiftyDayAverageChange": 0.6006, "fiftyDayAverageChangePercent": 0.1627907, "twoHundredDayAverageChange": 0.31299996, "twoHundredDayAverageChangePercent": 0.07870253, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "ipoExpectedDate": "2021-11-04", "averageAnalystRating": "2.4 - Buy", "shortName": "Evotec SE", "longName": "Evotec SE", "corporateActions": [], "postMarketTime": 1746230037, "regularMarketTime": 1746216000, "exchange": "NMS", "messageBoardId": "finmb_531375", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "marketState": "CLOSED", "regularMarketChangePercent": 1.4184383, "regularMarketPrice": 4.29, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1075991400000, "postMarketChangePercent": 0.687646, "postMarketPrice": 4.3195, "postMarketChange": 0.0295, "regularMarketChange": 0.059999943, "regularMarketDayRange": "4.27 - 4.38", "fullExchangeName": "NasdaqGS", "averageDailyVolume3Month": 83459, "cryptoTradeable": false, "trailingPegRatio": null, "__fetch_time": "2025-05-03"}]